The scientist’s investigation covers issues in Internal medicine, Cardiology, Myocardial infarction, Surgery and Atrial fibrillation. His study looks at the relationship between Internal medicine and fields such as Anesthesia, as well as how they intersect with chemical problems. His studies link Platelet aggregation inhibitor with Cardiology.
The concepts of his Atrial fibrillation study are interwoven with issues in Stroke, Antithrombotic and Anticoagulant. Freek W.A. Verheugt interconnects Stent and Conventional PCI in the investigation of issues within Percutaneous coronary intervention. His Randomized controlled trial research includes elements of Clinical trial and MEDLINE.
Freek W.A. Verheugt mostly deals with Internal medicine, Cardiology, Myocardial infarction, Atrial fibrillation and Surgery. His study on Aspirin, Stroke, Percutaneous coronary intervention and Acute coronary syndrome is often connected to In patient as part of broader study in Internal medicine. His biological study spans a wide range of topics, including Platelet aggregation inhibitor and Conventional PCI.
His Myocardial infarction study combines topics from a wide range of disciplines, such as Artery and Fibrinolysis. His work deals with themes such as Anticoagulant and Anesthesia, which intersect with Atrial fibrillation. His research integrates issues of Intensive care medicine and Antithrombotic in his study of Surgery.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Atrial fibrillation, Stroke and Percutaneous coronary intervention. His Myocardial infarction, Acute coronary syndrome, Coronary artery disease and Antithrombotic study in the realm of Internal medicine connects with subjects such as In patient. His Cardiology research focuses on subjects like Chronic fatigue syndrome, which are linked to Orthostatic intolerance.
His Atrial fibrillation research includes themes of Anticoagulant and Cohort. His research in Stroke tackles topics such as Intensive care medicine which are related to areas like Oral anticoagulation. His Percutaneous coronary intervention study combines topics in areas such as Anesthesia, Randomized controlled trial, Surgery, Conventional PCI and Aspirin.
His primary scientific interests are in Internal medicine, Atrial fibrillation, Stroke, Percutaneous coronary intervention and Cardiology. His work on Antithrombotic, Coronary artery disease, Myocardial infarction and Heart failure as part of general Internal medicine research is frequently linked to In patient, thereby connecting diverse disciplines of science. The study incorporates disciplines such as Embolism, Cohort and Intensive care medicine in addition to Atrial fibrillation.
Freek W.A. Verheugt has researched Stroke in several fields, including Anticoagulant, Prospective cohort study, Clinical trial and Kidney disease. His Percutaneous coronary intervention research is multidisciplinary, incorporating perspectives in Stent, Surgery, Conventional PCI and Acute coronary syndrome. Freek W.A. Verheugt studies Cardiology, focusing on Transcranial Doppler in particular.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).
Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray.
European Journal of Heart Failure (2008)
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
A. John Camm;Gregory Y.H. Lip.
European Heart Journal (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008
John Camm;Veronica Dean;Jose Luis Zamorano;Perry M. Elliott.
European Heart Journal (2008)
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.
Frans Van de Werf;Jeroen Bax;Amadeo Betriu;Carina Blomstrom-Lundqvist.
European Heart Journal (2008)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).
Marco Valgimigli;Héctor Bueno;Robert A Byrne;Jean-Philippe Collet.
European Heart Journal (2018)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli;Héctor Bueno;Robert A. Byrne;Jean-Philippe Collet.
European Journal of Cardio-Thoracic Surgery (2018)
Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.
Frans Van de Werf;Diego Ardissino;Amadeo Betriu;Dennis V. Cokkinos.
European Heart Journal (2003)
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
Willem J. M. Dewilde;Tom Oirbans;Freek W. A. Verheugt;Johannes C. Kelder.
The Lancet (2013)
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
C Michael Gibson;Roxana Mehran;Christoph Bode;Jonathan Halperin.
The New England Journal of Medicine (2016)
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru.
The New England Journal of Medicine (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: